IVERIC bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
IVERIC bio, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $109.66 million as of 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2023-03-01
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $109.66M.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $88.82M.
- 2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $20.55M.
- 2019-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $28.48M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value |
|---|---|
| 2022-12-31 | $109.66M 10-K · filed 2023-03-01 |
| 2021-12-31 | $88.82M 10-K · filed 2022-02-24 |
| 2020-12-31 | $20.55M 10-K · filed 2021-03-04 |
| 2019-12-31 | $28.48M 10-K · filed 2020-02-27 |
| 2018-12-31 | $3.00K 10-K · filed 2019-02-28 |
| 2018-09-30 | $44.00K 10-Q · filed 2018-11-02 |
| 2018-06-30 | $73.00K 10-Q · filed 2018-08-01 |
| 2018-03-31 | $75.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $492.00K 10-K · filed 2018-03-05 |
| 2017-09-30 | $114.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $83.00K 10-Q · filed 2017-08-02 |
| 2017-03-31 | $141.00K 10-Q · filed 2017-05-03 |
| 2016-12-31 | $254.00K 10-K · filed 2017-02-28 |
| 2016-09-30 | $38.23M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $57.03M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $37.74M 10-Q · filed 2016-05-09 |
| 2014-09-30 | $81.59M 10-Q · filed 2014-11-12 |